] i increases after OGD and is associated with worsened seizure activity, reduced efficacy of GABAergic anticonvulsants, and amelioration by antagonists of secondary chloride transport.
Introduction
Electrographic seizure activity is a prominent element of the neuronal dysfunction caused by hypoxic ischemic brain injury. 1, 2 Seizures in the setting of global hypoxic ischemic brain injury are associated with a poorer prognosis for recovery, raising the possibility that the seizures contribute to brain injury. 3, 4 Status epilepticus (SE) is considered to be a medical emergency because of the possibility of ictal brain injury. 5 Seizures increase the cerebral metabolic rate, that is, the demand for oxygen and glucose. 6 Ictal brain injury occurs much more rapidly in the setting of systemic hypotension, hypoxia, and hypoglycemia. 7 Following SE, neuropathological changes that are characteristic of hypoxic ischemic injury are observed in the hippocampus and cortex. 8, 9 These findings suggest that insufficient oxygen and glucose delivery contribute to ictal brain injury. 10 However, the mechanisms by which oxygen glucose deprivation (OGD) and seizure activity interact to produce brain injury remain poorly understood. 11 Seizures following hypoxic ischemic brain injury respond poorly to anticonvulsants. 12, 13 Similarly, at SE durations associated with brain injury, 8 seizure response to anticonvulsants is also reduced.
14 One mechanism for reduced anticonvulsant efficacy is endocytosis of inhibitory GABA A receptors. 15 We recently proposed a second mechanism. 16 Both SE and HIE are characterized by cytotoxic edema manifest on MRI by reduced diffusion. 17 Cytotoxic edema results from the entry of salt and water into the cytoplasm. 18, 19 The chloride moiety of the cytoplasmic salt will increase the neuronal chloride concentration, 20 creating a positive shift in the reversal potential for GABA A receptor chloride currents. This positive shift in reversal potential will create more depolarizing responses to GABA, which may result in excitation rather than inhibition of the neuron. Because most anticonvulsants used in the setting of SE and HIE increase the open time of the GABA A receptor, [21] [22] [23] chloride accumulation in neurons could substantially degrade the response to anticonvulsants. Restricting salt entry into neurons using diuretics improves the response to anticonvulsants in some experimental conditions. This has been explored in the setting of chemo-convulsant-induced seizures 24 or hypoxia-induced seizures, 25 but not in the setting of status epilepticus and HIE.
Here we test the effects of OGD on recurrent seizure activity and neuronal chloride concentration in a spontaneously epileptic in vitro preparation, the organotypic hippocampal slice culture preparation. 26, 27 This in vitro preparation permits the study of OGD that is more severe than can be survived by in vivo experimental preparations subject to global hypoxia and ischemia. 28 Reperfusion is also more feasible in vitro than in vivo. 29 We report the effects of 30 min of OGD on seizure activity and [Cl À ] i during OGD and after reperfusion and the response to anticonvulsants and diuretics.
Methods
All animal-use protocols were in accordance with the guidelines of the National Institute of Health and the Massachusetts General Hospital Center for Comparative Medicine on the use of laboratory animals, and approved by the Subcommittee on Research and Animal Care (SRAC).
Culture of organotypic hippocampal slices and experimental conditions
Transverse 350 lm hippocampal slices were prepared from C57BL/6 and CLM1 (Duke University Medical Center, Durham, NC, USA) mice at postnatal (P) day 6-7 as previously described. 26, 27 Acute slices were mounted on poly-L-Lysine coated glass coverslips (Electron Microscopy Sciences, Hatfield, PA). Slices were incubated in 1000 lL of NeuroBasal/B27(1X) medium (Gibco by Life Technologies, Grant Island, NY) supplemented with 0.5 mmol/L GlutaMAX and 30 lg/mL gentamicin (all from Invitrogen) in 6-well plates with low evaporation lid (Becton Dickinson Labware, Franklin Lakes, NJ), in a humidified 37°C atmosphere that contained 5% CO 2 , placed on a rocking platform (<1 cycle/min). Culture medium was changed biweekly. For acute recordings and imaging, slices were transferred to a submerged chamber and continuously superfused in oxygenated (95% O 2 and 5% CO 2 ) artificial cerebrospinal fluid (ACSF) containing (in mmol/L): 126 NaCl, 3.5 KCl, 2 CaCl 2, 1.3 MgCl 2 , 25 NaHCO 3 , 1.2 NaHPO 4 , and 11 Glucose (pH 7.4) at 32 AE 0.5°C and a flow rate of 2 mL/min. Oxygen-glucose deprivation (OGD) was induced by perfusion with anoxic ACSF saturated with 95% N 2 and 5% CO 2 , and glucose was substituted with equimolar concentration of mannitol. All organotypic hippocampal slices were used at Day in Vitro (DIV) 10-15. Pharmacological studies included NKCC1 specific blocker Bumetanide (10 lmol/L), a less selective cationchloride co-transport inhibitor Furosemide (1 mmol/L), sodium voltage-gated channel antagonist Tetrodotoxine (1 lmol/L), and Phenobarbital (100 lmol/L).
Electrophysiological recordings and data analysis
Extracellular field potentials were recorded in the CA3 and CA1 pyramidal cell layer of organotypic hippocampal slices using custom-made tungsten-coated 50 lm wire microelectrodes. The electrical signals were digitized using an analog-to-digital converter DigiData 1322A (Axon Instruments). pClamp and Clampfit 10.3 (Axon Instruments), Origin 7.5 (Microcal Software), and SigmaPlot 11.0 (Systat Software) programs were used for data acquisition and analysis. Recordings were sampled at 10 kHz. Interictal epileptiform discharges (IEDs) were defined as synchronous network-driven bursts characterized by short (0.1-3 sec) duration and large amplitude population spikes. The frequency, duration, and amplitude of IEDs substantially varied between recurrent ictal-like discharges. Ictal-like discharges (ILDs) were defined as hyper-synchronous, large amplitude, and high-frequency population spikes followed by sustained ictal-tonic and/or intermittent ictal-clonic after discharges, with the duration of the population spikes and after-discharge complex lasting more than 5 sec. Power spectrum analysis was performed on the electrical recordings after filtering with a Bessel high-pass filter of 1 Hz and applying a Hamming window function. The power of the electrical activity was calculated by integrating the root mean square value of the signal amplitude in corresponding time windows and frequency range from 1 to 1000 Hz. For comparison between slices, power was normalized for each slice with the highest value in control conditions. 30 For morphological analysis, organotypic slices were imaged through the CA1 pyramidal cell layer (Z-axis dimension 0-100 lm, 1-2 lm step size). ImageJ 1.51 software (National Institutes of Health) was used for quantitative analysis. Region of interests (ROIs) were selected using the chloride insensitive CFP fluorescence. The ratio of the YFP/CFP fluorescence intensity was used for [Cl À ] i calculation. 30, 33, 34 The CFP emission of Clomeleon was used for the high-resolution morphological analysis.
33,35

Statistical analysis
Group measures are expressed as mean AE standard deviation (SD) or median AE SD as indicated. The statistical significance of differences was assessed with the Student's t test. One-way repeated measures analysis of variance (One-Way RM ANOVA) was used to evaluate the differences in the mean values among the control and treatment groups. The Tukey Test was used for all pairwise comparisons of the mean responses to the different treatment groups. Friedman repeated measures analysis of variance on ranks (Friedman RM ANOVA on Ranks) was used to compare the differences in the median values among the treatment groups. Wilcoxon Signed Rank Test was used for nonparametric paired data analysis. The level of significance was set at P < 0.05.
Results
Transient OGD facilitated severity of recurrent seizures
The effects of transient 30 min oxygen-glucose deprivation (OGD) on spontaneous epileptiform activity were studied in mouse organotypic hippocampal slice cultures in vitro at DIV10 to DIV14. Electrical activity was monitored by simultaneous extracellular field potential recordings in the pyramidal cell layer of CA1 regions.
In control conditions, spontaneous neuronal network activity in the organotypic hippocampal slice cultures (N = 6) was characterized by short interictal epileptiform discharges (IEDs) and prolonged recurrent ictal-like epileptiform discharges (ILDs) resembling seizure activity (Fig. 1A) . 27, 36 Oxygen-glucose deprivation induced an initial increase in the mean duration of ILDs from 0.62 AE 0.2 to 1.52 AE 0.41 min (mean AE SD; N = 6; P = 0.004, One-Way RM ANOVA, Tukey Test), followed by suppression of epileptiform discharges ( Decreased duration was offset by increased frequency so that net power was increased ( Fig. 1D-F) . The mean duration of ILDs decreased by 30% from control to 0.44 AE 0.6 min (P = 0.66; Fig. 1D ), and the mean frequency of ILDs significantly increased by 61% from control to 5.6 AE 2.8 ILD/10 min (P = 0.004; Fig. 1E ). The mean power of corresponding extracellular field potential activity increased by 27% from control to 1193.6 AE 443.6 lV 2 (P = 0.235; Fig. 1F ). Thus, transient 30 min OGD followed by reperfusion was accompanied by facilitation of spontaneous ictal-like discharges, significantly increasing the mean ILD frequency. We determined next whether the changes in recurrent ictal-like discharges observed after OGD correlate with changes in E GABA measured as a change in [Cl À ] i .
Transient OGD facilitated neuronal chloride accumulation
Significant alterations in neuronal ionic transport in recurrent seizures, 37 chronically epileptic tissue, 38 and after ischemia/OGD 20 raise the possibility that altered chloride homeostasis and GABA signaling significantly aggravate the both seizure activity and ischemic brain injury. We determined the effect of transient 30 min OGD on neuronal chloride concentration and morphological properties of neurons. Two-photon imaging of genetically encoded intracellular chloride indicator Clomeleon was performed in the organotypic hippocampal slice cultures (DIV11 to DIV15) that spontaneously develop ictal-like epileptiform discharges.
The ratio of YFP to CFP fluorescence was used to measure [Cl 2F ) and differences in cell count (Fig. 2G) . Thus, reperfusion after transient OGD is associated with a persistent [Cl À ] i elevation, which leads to a corresponding depolarizing shift of chloride-permeable GABA A receptor-mediated postsynaptic responses (E GABA ). Depolarizing GABA responses in large populations of neurons facilitate neuronal network activity, increase the probability (frequency) of recurrent ictal-like discharges and limit anticonvulsant efficacy of GABAergic anticonvulsant. 40, 41 Transient OGD reduced anticonvulsant efficacy of phenobarbital
We compared the effect of phenobarbital on spontaneous ictal-like discharges in control conditions and 1 h on recovery after OGD (Fig. 3) . Extracellular field potential recordings were performed in the CA1 pyramidal cell layer in DIV11 to DIV15 organotypic hippocampal slice cultures.
In the first group of experiments, we determined the effect of phenobarbital on spontaneous ILDs in control conditions (Fig. 3A, C, and D) . Extracellular field potential recordings revealed spontaneous interictal and ictallike epileptiform discharges (N = 6 of 6 slices). Bath application of phenobarbital (100 lmol/L) for 1 h significantly reduced the mean frequency of ILDs by 51% from 13.7 AE 5.8 to 7.2 AE 5 ILD/h (P < 0.001; N = 6; OneWay RM ANOVA, Tukey Test) and the mean power of extracellular field potential activity by 53% from 965 AE 337.5 lV 2 in control to 435 AE 146.7 lV 2 (P < 0.001). The mean frequency of spontaneous ILDs partially recovered during washing out of phenobarbital to 11.3 AE 3.6 ILD/h (P = 0.169; Fig. 3C ). The mean power of electrical activity remained depressed 1 h after washing out of phenobarbital (603.5 AE 243 lV 2 ; P = 0.007; Fig. 3D ). These effects reveal a significant anticonvulsant effect of phenobarbital in chronic ictal-like discharges. 42 In a second group of experiments, we determined the effect of transient 30 min OGD on anticonvulsive efficacy of phenobarbital (Fig. 3B-D) . One hour after recovery from OGD, bath application of phenobarbital (100 lmol/ L) for 1 h reduced the mean frequency of ILDs by 26% from 18 AE 11.4 to 13.3 AE 9.4 ILD/h (N = 7; P = 0.054) and the mean power of corresponding electrical activity in the CA1 pyramidal cell layer by 32% from 1162.2 AE 482.3 lV 2 to 785.4 AE 227.5 lV 2 (P = 0.01). The mean frequency of ILDs recovered during washing out of phenobarbital to 17.1 AE 7.8 ILD/h (P > 0.05; Fig. 3C ). The mean power of electrical activity recovered to 1062.7 AE 413.3 lV 2 (P = 0.67; Fig. 3D ) after washing out of phenobarbital. Thus, transient OGD induced neuronal chloride elevation and depolarizing shift in E GABA (Fig. 2) , associated with a reduction in the anticonvulsant efficacy of a GABAergic anticonvulsant phenobarbital.
Cation-chloride cotransporters contribute to OGD induced facilitation of recurrent seizures
We next determined the contribution of cation-chloride co-transporters to OGD-induced neuronal chloride elevation and facilitation of recurrent ictal-like discharges. First, we determined the efficacy of the Na (P = 0.001; Fig. 4F ). In contrast to control conditions, reperfusion in the presence of bumetanide prevented facilitation of recurrent seizures ( Fig. 4C and D) . On 30-60 min recovery from OGD, the mean frequency of recurrent ILDs significantly decreased by 62% from control to 5.5 AE 2.8 ILD/30 min (P < 0.001; Fig. 4E ), and the mean power of the corresponding electrical activity remained significantly decreased by 36% from control to 618 AE 493.8 lV 2 (P = 0.01; Fig. 4F ). In a second group of experiments, we determined the efficacy of furosemide to prevent OGD induced facilitation of recurrent ictal-like discharges in the organotypic hippocampal slice cultures in vitro (Fig. 4B and D) . Furosemide was applied at a concentration 1 mmol/L that blocks both NKCC1 and KCC2. Furosemide applied during OGD had no effect on extracellular field potential activity compared to control OGD (Fig. 4B-D) . The mean frequency of ILDs during exposure to OGD in the presence of furosemide decreased by 64% from 12 AE 6.7 ILD/30 min to 4.3 AE 2.3 ILD/30 min (P = 0.009; N = 6; One-Way RM ANOVA, Tukey Test; Fig. 4E ) and the mean power of extracellular field potential activity Summary data of the frequency of ILDs (C) and power of electrical activity (D) before, during, and after phenobarbital application in control and 1-1.5 h on recovery after OGD. In control, phenobarbital significantly reduced seizure frequency and power of electrical activity. On recovery from OGD, the effect of phenobarbital on ILD frequency was not significant. (C, D) N = 6 slices for each group; box range corresponds to 25-75 percentiles, whisker range -SD, median line and solid square -mean; *represents P < 0.05; **P < 0.01; ***P < 0.001; One-Way RM ANOVA, Tukey Test). Thus, inhibition of secondary cation-chloride cotransporters, including both NKCC1 and KCC2, has little effect during OGD. However, cotransporters contribute to facilitation of recurrent seizure activity during reperfusion following OGD.
Cation-chloride cotransporters contribute to OGD induced neuronal chloride accumulation
Both bumetanide and furosemide prevented the facilitation of recurrent ictal-like discharges that followed OGD. We next determined whether the anticonvulsant effects of bumetanide and furosemide correlated with the rate of changes in [Cl À ] i (Fig. 5) . We compared the rate of ] i significantly decreased by 25% to 6 AE 3.2 mmol/L from control value (P < 0.05) and the difference was 2.1 AE 2.8 mmol/ L (median AE SD; Fig. 5A, B, G, and H) .
In the presence of furosemide (1 ] i significantly decreased by 36% to 8.1 AE 3.1 mmol/L from control value (P < 0.05), and the difference was 4.4 AE 3.6 mmol/L (Fig. 5C, D, G, and H) . The rate of bumetanide and furosemide induced [Cl À ] i reduction on recovery after OGD correlates with the rate of reduction in seizure frequency and suppression of electrical activity (Fig. 5G-I ).
We also determined the role of recurrent ictal-like discharges in neuronal chloride accumulation during OGD and 60 min after recovery from OGD ( Fig. 5E-H) . Recurrent ictal-like discharges during and after recovery from OGD were suppressed by bath application of the Na ] i increased from control to 11.8 AE 5.3 mmol/L (P > 0.05). The effect of TTX on neuronal chloride changes 60 min after recovery from OGD was not significant (Fig. 5G and H) , suggesting that neuronal chloride transporters strongly contribute to OGD induced neuronal chloride accumulation and facilitation of recurrent ictal-like discharges.
Bumetanide enhanced anticonvulsive efficacy of Phenobarbital after OGD
Transient OGD induced neuronal chloride elevation associated with facilitation of recurrent seizures and reduction in the anticonvulsant efficacy of phenobarbital (Figs. 1-3 ). Bumetanide significantly reduced the rate of OGDinduced [Cl À ] i elevation ( Fig. 5G and H) . We determined the effect of NKCC1 blocker bumetanide in combination with phenobarbital on anticonvulsant resistant seizures after OGD (Fig. 6 ). One hour after recovery from OGD, bath application of phenobarbital (100 lmol/L) in combination with bumetanide (10 lmol/L) for 1 h significantly reduced the mean frequency of ILDs by 80% from 14.2 AE 6.1 to 3 AE 2.3 ILD/h (N = 6; P = 0.006; One-Way RM ANOVA, Tukey Test; Fig. 6A-C) and the mean power of extracellular field potential activity by 54% from 1023.2 AE 267.1 lV 2 in control to 472 AE 213.4 lV 2 (P = 0.002). The mean frequency of ILD and power of corresponding electrical activity recovered after washing out of drugs ( Fig. 6A and B) . The mean anticonvulsant effect of phenobarbital in combination with bumetanide during recovery from OGD was significantly higher than corresponding effect of phenobarbital alone (N = 6; P < 0.05; Kruskal-Wallis One-Way ANOVA, Holm-Sidak all pairwise multiple comparison; Fig. 6C ). Thus, bumetanide improved anticonvulsive efficacy of phenobarbital during recovery from OGD. Fig. 1 and 2 ). These effects could be inhibited during reperfusion, but not during OGD, by antagonists of neuronal cation chloride cotransporters.
Effects of transient OGD on neuronal network activity and intracellular chloride
Increased [Cl
À
] i during reperfusion after OGD has been demonstrated in quiescent brain tissue in vitro. 20 In this study, the preparation was chronically epileptic and seizure activity was evident prior to OGD. In the presence of spontaneous seizure activity, increases in [Cl À ] i began during OGD and continued during reperfusion. However, seizure activity was not necessary for increases in [Cl À ] i , either during OGD (when activity became suppressed), or Figure 6 . Bumetanide improves efficacy of phenobarbital after OGD. (A) Extracellular field potential recording in the CA1 pyramidal cell layer in the organotypic hippocampal slices in vitro. Phenobarbital (100 lmol/L) in combination with bumetanide was applied for 1 h after recovery from OGD. Examples of the ictal-like discharges are shown on an expanded time scale. Power spectra correspond to 1 h windows after recovery from OGD, before, during, and after Phenobarbital and bumetanide application. (B) Summary data of the frequency of ILDs and power of electrical activity before, during, and after phenobarbital in combination with bumetanide application 1-1.5 h on recovery after OGD. Phenobarbital in combination with bumetanide significantly reduced the frequency of ILDs and power of electrical activity (N = 6; *represents P < 0.05; **P < 0.01; ***P < 0.001; One-Way RM ANOVA, Tukey Test). (C) Summary data of the phenobarbital effects on ILD frequency and power of electrical activity in control, 1 h after recovery from OGD alone and in combination with bumetanide. Bumetanide improves anticonvulsant effect of phenobarbital during recovery from OGD. *represents P < 0.05 (Kruskal-Wallis One-Way ANOVA on Ranks; Dunn's method). (Fig. 5A-G) . Both KCC2, which may run in reverse to import Cl À , 16 and NKCC1, whose canonical transport direction is inward, can serve to increase [Cl À ] i postictally. 16 Thus furosemide, which blocks both KCC2 and NKCC1 cotransporters at 1 mmol/L, was more effective than bumetanide, which at 10 lmol/L primarily blocks NKCC1. 45 ] i are sufficient to shift E GABA to the point that GABA A receptor activation is depolarizing and excitatory. This will compromise the efficacy of GABAergic anticonvulsants that increase the mean open time of the GABA A receptor regulated chloride channels, such as benzodiazepines and barbiturates. 22 
Clinical relevance
Although seizures occur in animals subject to ongoing hypoxia and/or ischemia, 28, 48 it is difficult to relate these phenomena to clinical practice. Seizures do not occur during resuscitation or acute endovascular treatment of stroke. 49, 50 Clinically, the first therapeutic goal in hypoxia and/or ischemia is immediate re-establishment of normoxia and adequate perfusion, rather than EEG monitoring or administration of anticonvulsants. In the face of hypoxia and/or ischemia, primary ion transport will be compromised: Na + -K + -ATPase will not generate sodium and potassium gradients in the absence of ATP. ATP is generated by oxidative phosphorylation, which requires oxygen and an oxidizable substrate such as glucose. Thus in the absence of oxygen and glucose, neither primary nor secondary transport will be effective, and neither will blockade of secondary transporters. 48 During reperfusion after hypoxia and ischemia, or after prolonged episodes of status epilepticus, seizures often do not respond to GABAergic anticonvulsants. [51] [52] [53] [54] One possible etiology is the increase in neuronal chloride observed in this study, and the consequent positive shift in GABA reversal potential. Blocking cation-chloride cotransporters with diuretic antagonists should enhance the efficacy of these anticonvulsants (Fig. 6 ). An initial uncontrolled trial of the NKCC1 antagonist bumetanide was not successful, 55, 56 but a controlled trial has recently completed enrollment (clinicaltrials.gov # NCT00830531).
Future directions
This study identifies pathways for Cl À entry into neurons after OGD, but not the pathophysiology that drives this entry. Damage to the brain's extracellular matrix has recently been proposed to shift the Donnan equilibria that determine the chloride steady-state concentrations on either side of neuronal membranes. 16 In this scheme, cotransporters facilitate the re-establishment of equilibrium by increasing cytoplasmic chloride after damage to the extracellular matrix. Diuretics interfere with this equilibrative increase in cytoplasmic chloride. It may be more effective to inhibit the activity of matrix metalloproteinases 57 to reduce the amount of damage to the extracellular matrix, reduce the driving force for neuronal chloride entry, and so preserve the efficacy of GABAergic anticonvulsants.
